| Introduction | ingavirin is a research and development team of Russian military Virus scientist and chief therapist academician Alexander, launched by one of the largest pharmaceutical companies in Russia, the new anti Virus product, which is against influenza (H3N2 subtype, HlNl influenza A, H5N1), type B Virus, adenovirus Virus with high anti Virus efficacy. |
| mechanism of action | ingavirin inhibits Virus of the nuclear replication phase, which is different from the current mechanism of action of anti-Virus drugs, ingavirin inhibits the migration of a newly synthesized Virus NP protein from the cytoplasm to the nucleus, which is an important stage in Virus of infected hosts. |
| Use | ingavirin is useful in the treatment of influenza Virus, as well as in immunomodulatory and anti-inflammatory responses. |
